Spots Global Cancer Trial Database for interferon alpha
Every month we try and update this database with for interferon alpha cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combined Use of BCG and Interferon Alpha in Bladder Cancer | NCT00330707 | Carcinoma of Ur... | Bacillus Calmet... | 18 Years - | National University Hospital, Singapore | |
| Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan | NCT02776644 | Renal Cell Carc... | - | Pfizer | ||
| Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | NCT00333840 | Chronic Myeloge... | imatinib mesila... interferon-alph... cytarabine (ARA... | 18 Years - 70 Years | Novartis | |
| Cognitive Effects of Interferon in Patients With Melanoma | NCT02074605 | Melanoma | Interferon alph... | 18 Years - | University of Arizona | |
| Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies | NCT00038376 | Lymphoma, T-Cel... Mycosis Fungoid... Hematologic Neo... | Isotretinoin (A... Interferon Alph... | 18 Years - | M.D. Anderson Cancer Center | |
| PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron | NCT00037882 | Leukemia, Myelo... | PEG-Intron | - | M.D. Anderson Cancer Center | |
| Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms | NCT05850273 | Myeloproliferat... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | ||
| Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00062010 | Lung Cancer | interferon alph... 13-cis-retinoic... paclitaxel | 18 Years - | Eastern Cooperative Oncology Group | |
| Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma | NCT00679289 | Metastatic Mela... Cutaneous Melan... | HDI KW2871 KW2871 KW2871 | 18 Years - | Ludwig Institute for Cancer Research | |
| Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan | NCT02776644 | Renal Cell Carc... | - | Pfizer | ||
| Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | NCT00504140 | Osteosarcoma | Etoposide Interferon Alph... | 5 Years - 70 Years | M.D. Anderson Cancer Center | |
| Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | NCT00504140 | Osteosarcoma | Etoposide Interferon Alph... | 5 Years - 70 Years | M.D. Anderson Cancer Center | |
| Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | NCT00333840 | Chronic Myeloge... | imatinib mesila... interferon-alph... cytarabine (ARA... | 18 Years - 70 Years | Novartis | |
| Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma | NCT00679289 | Metastatic Mela... Cutaneous Melan... | HDI KW2871 KW2871 KW2871 | 18 Years - | Ludwig Institute for Cancer Research | |
| Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM) | NCT00633542 | Multiple Myelom... | thalidomide interferon alph... | 18 Years - | Università Politecnica delle Marche |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
